InsiderTrades.com logo

TERN Insider Trading

Insider Ownership Percentage: 1.50%
Insider Buying (Last 12 Months): $297,042.68
Insider Selling (Last 12 Months): $665,822.98

Terns Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Terns Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Terns Pharmaceuticals Share Price & Price History

Current Price: $27.13
Price Change: ▼ Price Decrease of -0.36 (-1.31%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for TERN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Terns Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/4/2025Jill M QuigleyDirectorSell24,520$18.00$441,360.00View SEC Filing Icon  
10/1/2025Emil KuriakoseInsiderSell944$7.85$7,410.4051,520View SEC Filing Icon  
7/1/2025Emil KuriakoseInsiderSell853$4.27$3,642.3152,464View SEC Filing Icon  
6/27/2025Andrew GengosCFOBuy10,000$3.93$39,300.0025,000View SEC Filing Icon  
6/25/2025Amy L BurroughsCEOBuy23,314$3.87$90,225.1847,083View SEC Filing Icon  
6/16/2025Andrew GengosCFOBuy5,000$3.95$19,750.0015,000View SEC Filing Icon  
6/13/2025Andrew GengosCFOBuy10,000$3.73$37,300.0010,000View SEC Filing Icon  
4/1/2025Emil KuriakoseInsiderSell952$2.49$2,370.4853,317View SEC Filing Icon  
1/6/2025Jill M. QuigleyDirectorSell8,760$5.79$50,720.40View SEC Filing Icon  
1/6/2025Mark J VignolaCFOSell9,059$5.80$52,542.2074,752View SEC Filing Icon  
1/2/2025Emil KuriakoseInsiderSell4,481$5.71$25,586.5154,269View SEC Filing Icon  
1/2/2025Jill M QuigleyDirectorSell6,240$5.72$35,692.808,760View SEC Filing Icon  
1/2/2025Mark J VignolaCFOSell8,129$5.72$46,497.8883,811View SEC Filing Icon  
12/5/2024Amy L BurroughsCEOBuy15,450$7.15$110,467.5019,099View SEC Filing Icon  
11/30/2024Amy L BurroughsCEOBuy510$5.11$2,606.1019,609View SEC Filing Icon  
11/30/2024Melita Sun JungInsiderBuy2,250$5.11$11,497.502,250View SEC Filing Icon  
9/12/2024Hongbo LuDirectorBuy476,190$10.50$4,999,995.00476,190View SEC Filing Icon  
9/10/2024Mark J VignolaCFOSell10,000$11.00$110,000.0091,940View SEC Filing Icon  
9/9/2024Jill M QuigleyDirectorSell17,235$10.00$172,350.0015,000View SEC Filing Icon  
8/1/2024Jill M QuigleyDirectorSell6,143$7.68$47,178.2423,857View SEC Filing Icon  
7/15/2024Carl L GordonDirectorSell50,976$10.00$509,760.00756,258View SEC Filing Icon  
4/3/2024Vivo Opportunity, LlcMajor ShareholderSell138,066$6.20$856,009.20268,573View SEC Filing Icon  
4/1/2024Vivo Opportunity, LlcMajor ShareholderSell181,117$6.99$1,266,007.83275,772View SEC Filing Icon  
12/23/2022Orbimed Advisors LlcDirectorBuy137,931$7.25$999,999.754,882,854View SEC Filing Icon  
12/23/2022Vivo Opportunity, LlcMajor ShareholderBuy758,620$7.25$5,499,995.004,340,212View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Terns Pharmaceuticals (NASDAQ:TERN)

98.26% of Terns Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TERN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Terns Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2025CIBC Bancorp USA Inc.12,708$95K0.0%N/A0.014%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.136,979$1.03M0.0%-32.4%0.152%Search for SEC Filing on Google Icon
11/17/2025Caxton Associates LLP15,168$0.11M0.0%N/A0.017%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP292,055$2.19M0.0%-3.2%0.324%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management US LLC10,144$76K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd76,782$0.58M0.0%-77.2%0.085%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC934,760$7.02M0.7%+14.3%1.038%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC941,584$7.07M0.0%-5.5%1.045%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.33,976$0.26M0.0%-14.6%0.038%Search for SEC Filing on Google Icon
11/17/2025Cinctive Capital Management LP77,555$0.58M0.0%-29.5%0.086%Search for SEC Filing on Google Icon
11/17/2025Commodore Capital LP5,700,000$42.81M2.1%N/A6.328%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE704,773$5.29M0.0%+42.7%0.782%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC178,875$1.34M0.0%+216.8%0.199%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC1,891,925$14.21M0.1%-38.0%2.100%Search for SEC Filing on Google Icon
11/14/2025Zacks Investment Management36,100$0.27M0.0%+142.9%0.040%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC10,000$75K0.0%-64.8%0.011%Search for SEC Filing on Google Icon
11/14/2025Acuta Capital Partners LLC502,797$3.78M3.9%+8.4%0.558%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP34,030$0.26M0.0%-83.4%0.038%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC12,734$96K0.0%-85.5%0.014%Search for SEC Filing on Google Icon
11/14/2025Integral Health Asset Management LLC950,000$7.13M0.5%+35.7%1.055%Search for SEC Filing on Google Icon
11/13/2025Platinum Investment Management Ltd.125,156$0.94M0.1%N/A0.139%Search for SEC Filing on Google Icon
11/13/2025Invesco Ltd.477,674$3.59M0.0%+405.3%0.546%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG972,772$7.31M0.0%-17.0%1.112%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets86,309$0.65M0.0%-83.0%0.099%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc6,224$47K0.0%-8.0%0.007%Search for SEC Filing on Google Icon
11/13/2025WINTON GROUP Ltd65,681$0.49M0.0%N/A0.075%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.32,172$0.24M0.0%+29.6%0.037%Search for SEC Filing on Google Icon
11/13/2025DLD Asset Management LP10,000$75K0.0%-73.0%0.011%Search for SEC Filing on Google Icon
11/13/2025Schroder Investment Management Group217,931$1.70M0.0%-42.1%0.249%Search for SEC Filing on Google Icon
11/13/2025Dynamic Technology Lab Private Ltd66,576$0.50M0.1%+237.2%0.076%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC130,391$0.98M0.0%-46.7%0.149%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP1,456,401$10.94M0.0%-11.8%1.664%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC30,993$0.23M0.0%-32.8%0.035%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.11,610$87K0.0%N/A0.013%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.15,339$0.12M0.0%-12.6%0.018%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.4,559,917$34.25M0.0%+5.9%5.211%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.682,708$5.13M0.0%+90.6%0.780%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers104,837$0.79M0.0%-1.5%0.120%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC12,759$96K0.0%N/A0.015%Search for SEC Filing on Google Icon
11/6/2025ProShare Advisors LLC15,481$0.12M0.0%-14.4%0.018%Search for SEC Filing on Google Icon
11/6/2025Oppenheimer & Co. Inc.12,466$94K0.0%N/A0.014%Search for SEC Filing on Google Icon
11/5/2025Alps Advisors Inc.42,630$0.32M0.0%-9.6%0.049%Search for SEC Filing on Google Icon
11/3/2025AlphaQuest LLC90,883$0.68M0.0%+9,088,200.0%0.104%Search for SEC Filing on Google Icon
10/31/2025Stoneridge Investment Partners LLC16,867$0.13M0.1%-18.1%0.019%Search for SEC Filing on Google Icon
10/14/2025Exchange Traded Concepts LLC121,455$0.91M0.0%-46.7%0.139%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC13,666$0.10M0.0%-32.3%0.016%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP11,056$41K0.0%N/A0.013%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets506,777$1.89M0.0%+11.6%0.579%Search for SEC Filing on Google Icon
8/15/2025Boothbay Fund Management LLC56,464$0.21M0.0%-55.5%0.065%Search for SEC Filing on Google Icon
8/15/2025Bridgeway Capital Management LLC95,000$0.35M0.0%N/A0.109%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE493,805$1.84M0.0%-39.2%0.564%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.1,280,000$4.77M0.0%N/A1.463%Search for SEC Filing on Google Icon
8/14/2025Acuta Capital Partners LLC463,864$1.73M2.4%+42.5%0.530%Search for SEC Filing on Google Icon
8/14/2025Canada Pension Plan Investment Board12,300$46K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.39,784$0.15M0.0%-4.3%0.045%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 27,262$0.10M0.0%+8.3%0.031%Search for SEC Filing on Google Icon
8/14/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 273,619$1.02M0.1%-18.6%0.313%Search for SEC Filing on Google Icon
8/14/2025Velan Capital Investment Management LP20,000$75K0.1%+17.6%0.023%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd336,665$1.26M0.0%-51.6%0.385%Search for SEC Filing on Google Icon
8/13/2025Walleye Capital LLC376,559$1.41M0.0%-36.6%0.430%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.94,534$0.35M0.0%+62.0%0.108%Search for SEC Filing on Google Icon
8/13/2025DLD Asset Management LP37,047$0.14M0.0%N/A0.042%Search for SEC Filing on Google Icon
8/13/2025Russell Investments Group Ltd.24,820$93K0.0%-11.9%0.028%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd29,515$0.11M0.0%N/A0.034%Search for SEC Filing on Google Icon
8/12/2025American Century Companies Inc.129,668$0.48M0.0%+14.0%0.148%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers106,451$0.40M0.0%+10.1%0.122%Search for SEC Filing on Google Icon
8/12/2025Franklin Resources Inc.1,277,396$4.77M0.0%N/A1.460%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.358,206$1.34M0.0%+21.8%0.409%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC46,121$0.17M0.0%+15.5%0.053%Search for SEC Filing on Google Icon
8/8/2025Candriam S.C.A.2,368,235$8.83M0.1%+9.9%2.706%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC1,633,349$6.09M0.0%+3.8%1.866%Search for SEC Filing on Google Icon
7/23/2025Vontobel Holding Ltd.10,000$37K0.0%-28.6%0.011%Search for SEC Filing on Google Icon
7/15/2025LeConte Wealth Management LLC12,641$47K0.0%N/A0.014%Search for SEC Filing on Google Icon
7/10/2025Exchange Traded Concepts LLC227,847$0.85M0.0%+65.5%0.261%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.415,021$1.15M0.0%+21.0%0.475%Search for SEC Filing on Google Icon
5/16/2025Woodline Partners LP301,612$0.83M0.0%-3.2%0.345%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.415,021$1.15M0.0%+21.0%0.475%Search for SEC Filing on Google Icon
5/16/2025Dynamic Technology Lab Private Ltd18,578$51K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/16/2025Parkman Healthcare Partners LLC959,703$2.65M0.3%+15.8%1.099%Search for SEC Filing on Google Icon
5/16/2025Jacobs Levy Equity Management Inc.494,877$1.37M0.0%N/A0.567%Search for SEC Filing on Google Icon
5/15/2025Cubist Systematic Strategies LLC28,327$78K0.0%+136.8%0.032%Search for SEC Filing on Google Icon
5/15/2025Graham Capital Management L.P.226,295$0.63M0.0%+70.1%0.259%Search for SEC Filing on Google Icon
5/15/2025Driehaus Capital Management LLC763,486$2.11M0.0%-54.1%0.874%Search for SEC Filing on Google Icon
5/15/2025Trexquant Investment LP139,609$0.39M0.0%-44.9%0.160%Search for SEC Filing on Google Icon
5/14/2025MetLife Investment Management LLC21,880$60K0.0%-50.0%0.025%Search for SEC Filing on Google Icon
5/14/2025Walleye Capital LLC594,190$1.64M0.0%+399.8%0.680%Search for SEC Filing on Google Icon
5/14/2025Jump Financial LLC13,900$38K0.0%-77.7%0.016%Search for SEC Filing on Google Icon
5/14/2025Martingale Asset Management L P83,038$0.23M0.0%-15.4%0.095%Search for SEC Filing on Google Icon
5/14/2025EntryPoint Capital LLC73,293$0.20M0.1%+21.4%0.084%Search for SEC Filing on Google Icon
5/14/2025Hsbc Holdings PLC23,515$66K0.0%-34.5%0.027%Search for SEC Filing on Google Icon
5/14/2025Wellington Management Group LLP321,163$0.89M0.0%+44.3%0.368%Search for SEC Filing on Google Icon
5/13/2025Russell Investments Group Ltd.28,188$78K0.0%-95.5%0.032%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC1,405,901$3.88M0.0%N/A1.610%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.58,345$0.16M0.0%+149.3%0.067%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG385,477$1.06M0.0%-3.2%0.441%Search for SEC Filing on Google Icon
4/28/2025Vontobel Holding Ltd.14,000$39K0.0%N/A0.016%Search for SEC Filing on Google Icon
4/17/2025Exchange Traded Concepts LLC137,663$0.38M0.0%-3.7%0.158%Search for SEC Filing on Google Icon
4/15/2025SG Americas Securities LLC413,822$1.14M0.0%+1,141.5%0.474%Search for SEC Filing on Google Icon
4/11/2025E. Ohman J or Asset Management AB102,410$0.28M0.0%+27.4%0.117%Search for SEC Filing on Google Icon
4/10/2025Thrive Wealth Management LLC10,500$29K0.0%N/A0.012%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Terns Pharmaceuticals logo
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Read More on Terns Pharmaceuticals

Today's Range

Now: $27.13
Low: $26.53
High: $28.17

50 Day Range

MA: $15.69
Low: $7.50
High: $29.34

52 Week Range

Now: $27.13
Low: $1.87
High: $29.51

Volume

3,624,545 shs

Average Volume

3,266,852 shs

Market Capitalization

$2.44 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Terns Pharmaceuticals?

Terns Pharmaceuticals' top insider shareholders include:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Vivo Opportunity, Llc (Major Shareholder)
  4. Mark J Vignola (CFO)
  5. Emil Kuriakose (Insider)
  6. Amy L Burroughs (CEO)
  7. Andrew Gengos (CFO)
  8. Jill M Quigley (Director)
  9. Melita Sun Jung (Insider)
  10. Jill M Quigley (Director)
Learn More about top insider investors at Terns Pharmaceuticals.

Who are the major institutional investors of Terns Pharmaceuticals?

Terns Pharmaceuticals' top institutional shareholders include:
  1. Commodore Capital LP — 6.33%
  2. Vanguard Group Inc. — 5.21%
  3. Schonfeld Strategic Advisors LLC — 2.10%
  4. Dimensional Fund Advisors LP — 1.66%
  5. UBS Group AG — 1.11%
  6. Integral Health Asset Management LLC — 1.05%
Learn More about top institutional investors of Terns Pharmaceuticals stock.

Which institutional investors are selling Terns Pharmaceuticals stock?

Within the last quarter, TERN stock was sold by these institutional investors:
  1. Schonfeld Strategic Advisors LLC
  2. BNP Paribas Financial Markets
  3. Qube Research & Technologies Ltd
  4. UBS Group AG
  5. Dimensional Fund Advisors LP
  6. Two Sigma Investments LP
  7. Schroder Investment Management Group
  8. Barclays PLC
Within the last year, company insiders that have sold Terns Pharmaceuticals company stock include:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Vivo Opportunity, Llc (Major Shareholder)
  4. Mark J Vignola (CFO)
Learn More investors selling Terns Pharmaceuticals stock.

Which institutional investors are buying Terns Pharmaceuticals stock?

In the previous quarter, TERN stock was acquired by institutional investors including:
  1. Commodore Capital LP
  2. Invesco Ltd.
  3. JPMorgan Chase & Co.
  4. Vanguard Group Inc.
  5. Integral Health Asset Management LLC
  6. Bank of America Corp DE
  7. Platinum Investment Management Ltd.
  8. Boothbay Fund Management LLC
During the last year, these company insiders have bought Terns Pharmaceuticals stock:
  1. Carl L Gordon (Director)
  2. Hongbo Lu (Director)
  3. Vivo Opportunity, Llc (Major Shareholder)
  4. Mark J Vignola (CFO)
Learn More investors buying Terns Pharmaceuticals stock.